RITA Medical Systems Announces First Quarter 2005 Results RITA Medical Systems Announces First Quarter 2005 Results FREMONT, Calif., May 10 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA), a leading medical oncology device company, today announced that growth in utilization and

RITA Medical Systems Announces Relocation of Corporate Headquarters; Company Moves from Mountain View, Calif. to New Offices in Fremont, Calif. RITA Medical Systems Announces Relocation of Corporate Headquarters; Company Moves from Mountain View, Calif. to New Offices in Fremont, Calif.

RITA Medical Systems to Hold First Quarter 2005 Conference Call on May 10, 2005 MOUNTAIN VIEW, Calif., April 20 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced plans to release its financial results for the first quarter ended March 31, 2005, at 8:55 a.m.

AngioDynamics Receives Favorable Markman Ruling in Diomed Litigation QUEENSBURY, N.Y.--(BUSINESS WIRE)--April 13, 2005--AngioDynamics, Inc. (NASDAQ:ANGO) announced a favorable Markman ruling in the patent lawsuit between Diomed Inc. and AngioDynamics, Inc.

AngioDynamics' CEO Eamonn Hobbs Granted Honorary Fellowship by Society of Interventional Radiology QUEENSBURY, N.Y.--(BUSINESS WIRE)--April 7, 2005--AngioDynamics, Inc. (NASDAQ:ANGO) today announced that Eamonn Hobbs, president and chief executive officer, was granted an Honorary Fellowship from

Society of Interventional Radiology Annual Meeting Features RITA Medical Systems Radiofrequency Ablation Technology in Press Releases and Scientific Sessions Society of Interventional Radiology Annual Meeting Features RITA Medical Systems Radiofrequency Ablation Technology in Press Releases and

New TALON Radiofrequency Ablation Device for Peripherally Located Tumors Introduced by RITA Medical Systems at Society of Interventional Radiology Annual Scientific Meeting MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--April 4, 2005-- Novel StarBurst ™ TALON ™ Radiofrequency Electrode Creates

Journal of Clinical Oncology Publishes Study of Colorectal Liver Metastases Patients Treated with Combination Radiofrequency Ablation and Chemotherapy Suggesting Survival Benefit Journal of Clinical Oncology Publishes Study of Colorectal Liver Metastases Patients Treated with Combination

Live Webcast April 22, 2005 2 pm EDT (1800 UTC)

RITA Medical Systems Meets 10K Extension Filing Deadline for 2004 MOUNTAIN VIEW, Calif., March 31 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that it filed its Form 10K for the year ended December 31, 2004 on March 31, 2005.

AngioDynamics Fiscal Third Quarter Operating Profit Nearly Doubles on Net Sales Growth of 24%; Conference Call to Begin Today at 4:30 p.m. ET QUEENSBURY, N.Y.--(BUSINESS WIRE)--March 29, 2005--AngioDynamics, Inc. (Nasdaq:ANGO) today announced financial results for the 13 and 39 weeks ended February

QUEENSBURY, N.Y., Mar 29, 2005 (BUSINESS WIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) today announced the release of the TOTAL ABSCESSION ™ general drainage catheter, a catheter designed to percutaneously drain abscesses and other fluid collections.

AngioDynamics to Hold Fiscal Third Quarter Financial Results Conference Call on Tuesday, March 29, 2005 QUEENSBURY, N.Y., Mar 22, 2005 (BUSINESS WIRE) -- AngioDynamics, Inc. (Nasdaq:ANGO) today announced that the company will release third quarter results on Tuesday, March 29, 2005 after market

AngioDynamics Provides Update on Diomed Litigation QUEENSBURY, N.Y., Mar 17, 2005 (BUSINESS WIRE) -- AngioDynamics, Inc. (NASDAQ:ANGO) today announced an update regarding developments in the lawsuit between Diomed Inc. and AngioDynamics, Inc. In January 2004, Diomed, Inc., a subsidiary of Diomed

RITA Medical Systems Requests 10K Filing Extension MOUNTAIN VIEW, Calif., March 16 /PRNewswire-FirstCall/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that it had filed for a 15-day extension of the filing deadline for its Form 10K for the year ended December 31, 2004.

RITA Medical Systems to Present at Wells Fargo Securities' 2005 Healthcare Conference MOUNTAIN VIEW, Calif., Feb 18, 2005 /PRNewswire-FirstCall via COMTEX/ -- RITA Medical Systems, Inc. (Nasdaq: RITA) today announced that President and CEO Joseph DeVivo is scheduled to make an investor presentation

Sales of $11 Million, $0.05 Loss per Share; Loss per Share $0.01 - Excluding Merger Related Expenses (Non-GAAP)

Radiology Society of North America Issues Press Release Announcing Publication of Study of Treatment for Liver Cancer Using RITA Medical Systems Radiofrequency Ablation Products Radiology Society of North America Issues Press Release Announcing Publication of Study of Treatment for Liver Cancer

Rita Medical Systems Names Jelle W. Kylstra, MD, MBA Vice President & Medical Director MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Feb. 15, 2005-- Dr. Kylstra to Lead Company's Medical Affairs Efforts Focused on Development and Acceptance of Radiofrequency Ablation As A Treatment for Cancer RITA

RITA MEDICAL SYSTEMS TO HOLD FOURTH QUARTER AND FISCAL YEAR 2004 CONFERENCE CALL ON FEBRUARY 16, 2005 Mountain View, Calif., January 11, 2005. . . RITA Medical Systems, Inc. (Nasdaq:RITA) today announced plans to release its financial results for the fourth quarter and fiscal year ended December